These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 14532270)
41. Parkin and the molecular pathways of Parkinson's disease. Giasson BI; Lee VM Neuron; 2001 Sep; 31(6):885-8. PubMed ID: 11580890 [TBL] [Abstract][Full Text] [Related]
42. The parkin-like human homolog of Drosophila ariadne-1 (HHARI) can induce aggresome formation in mammalian cells and is immunologically detectable in Lewy bodies. Parelkar SS; Cadena JG; Kim C; Wang Z; Sugal R; Bentley B; Moral L; Ardley HC; Schwartz LM J Mol Neurosci; 2012 Jan; 46(1):109-21. PubMed ID: 21590270 [TBL] [Abstract][Full Text] [Related]
43. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Marx FP; Holzmann C; Strauss KM; Li L; Eberhardt O; Gerhardt E; Cookson MR; Hernandez D; Farrer MJ; Kachergus J; Engelender S; Ross CA; Berger K; Schöls L; Schulz JB; Riess O; Krüger R Hum Mol Genet; 2003 Jun; 12(11):1223-31. PubMed ID: 12761037 [TBL] [Abstract][Full Text] [Related]
45. Effect of the neurotoxic dose of methamphetamine on gene expression of parkin and Pael-receptors in rat striatum. Nakahara T; Kuroki T; Ohta E; Kajihata T; Yamada H; Yamanaka M; Hashimoto K; Tsutsumi T; Hirano M; Uchimura H Parkinsonism Relat Disord; 2003 Mar; 9(4):213-9. PubMed ID: 12618056 [TBL] [Abstract][Full Text] [Related]
46. Neuroprotection of Parkin against apoptosis is independent of inclusion body formation. Yang H; Zhou HY; Li B; Chen SD Neuroreport; 2005 Jul; 16(10):1117-21. PubMed ID: 15973159 [TBL] [Abstract][Full Text] [Related]
47. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718 [TBL] [Abstract][Full Text] [Related]
48. Recent advances in research on Parkinson disease: synuclein and parkin. Burke RE Neurologist; 2004 Mar; 10(2):75-81. PubMed ID: 14998437 [TBL] [Abstract][Full Text] [Related]
49. Induction of macroautophagy by overexpression of the Parkinson's disease-associated GPR37 receptor. Marazziti D; Di Pietro C; Golini E; Mandillo S; Matteoni R; Tocchini-Valentini GP FASEB J; 2009 Jun; 23(6):1978-87. PubMed ID: 19218498 [TBL] [Abstract][Full Text] [Related]
56. [Physiological Roles of Ubiquitin Ligases Related to the Endoplasmic Reticulum]. Kaneko M Yakugaku Zasshi; 2016; 136(6):805-9. PubMed ID: 27252059 [TBL] [Abstract][Full Text] [Related]
57. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533 [TBL] [Abstract][Full Text] [Related]
59. Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells. Kyratzi E; Pavlaki M; Kontostavlaki D; Rideout HJ; Stefanis L J Neurochem; 2007 Aug; 102(4):1292-303. PubMed ID: 17472700 [TBL] [Abstract][Full Text] [Related]
60. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease. Yasuda T; Mochizuki H Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]